Fermentalg SA (FR:ALGAE)
:ALGAE
Top Page
Fermentalg SA
(ALGAE)
Select Model
Select Model
Rating:52Neutral
Price Target:
€0.47
▲(10.00% Upside)
Action:ReiteratedDate:01/14/26
The score is driven primarily by strong revenue growth and improved operating cash flow, tempered by continued large losses and very weak margins. Technicals are moderately supportive in the short term, while valuation is constrained by negative earnings and the absence of a dividend yield.
Positive Factors
Revenue Growth
183% revenue growth demonstrates meaningful commercial traction for Fermentalg's microalgae ingredients. Sustainable top-line expansion supports scale economics, helps absorb fixed costs, enables reinvestment in capacity and R&D, and strengthens long-term customer relationships if continued.
Negative Factors
Large Net Losses and Negative Margins
A €12.88M net loss with EBIT/EBITDA margins around -80%/-87% shows current unit economics are far from sustainable. Without durable margin recovery through cost improvements, pricing, or mix shifts toward higher-margin products, continued losses will require ongoing financing and hinder path to profitability.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue Growth
183% revenue growth demonstrates meaningful commercial traction for Fermentalg's microalgae ingredients. Sustainable top-line expansion supports scale economics, helps absorb fixed costs, enables reinvestment in capacity and R&D, and strengthens long-term customer relationships if continued.
Read all positive factors
Fermentalg SA (ALGAE) vs. iShares MSCI France ETF (EWQ)
Market Cap
€45.24M
Dividend YieldN/A
Average Volume (3M)224.33K
Price to Earnings (P/E)―
Beta (1Y)0.88
Revenue Growth59.05%
EPS Growth56.18%
CountryFR
Employees58
SectorHealthcare
Sector Strength45
IndustryBiotechnology
Share Statistics
EPS (TTM)-0.05
Shares Outstanding89,844,100
10 Day Avg. Volume242,064
30 Day Avg. Volume224,333
Financial Highlights & Ratios
PEG Ratio0.04
Price to Book (P/B)0.77
Price to Sales (P/S)2.21
P/FCF Ratio-12.69
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-0.08
Revenue Forecast (FY)€20.00M
Fermentalg SA Business Overview & Revenue Model
Company Description
Fermentalg SA develops, produces, and sells active ingredients extracted from microalgae for the food, health, nutrition, and environment sectors in France and internationally. It offers DHA ORIGINS, a plant-based DHA oil; KALVEA PLUS, a nutritiou...
How the Company Makes Money
Fermentalg generates revenue through multiple streams, primarily by selling its microalgae-derived products to various sectors. The company engages in direct sales of its omega-3 fatty acids and other ingredients to manufacturers in the food, diet...
Fermentalg SA Financial Statement Overview
Summary
Income Statement
45
Neutral
Balance Sheet
55
Neutral
Cash Flow
50
Neutral
| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 12.78M | 11.50M | 4.06M | 7.65M | 5.65M | 2.21M |
| Gross Profit | 2.68M | 2.50M | 536.00K | -828.00K | -675.00K | -1.25M |
| EBITDA | -8.60M | -9.99M | -10.91M | -7.19M | -8.91M | -6.16M |
| Net Income | -11.54M | -12.88M | -14.15M | -9.87M | -6.85M | -6.88M |
Balance Sheet | ||||||
| Total Assets | 46.99M | 51.14M | 50.24M | 57.54M | 60.88M | 41.89M |
| Cash, Cash Equivalents and Short-Term Investments | 12.84M | 20.58M | 11.16M | 15.90M | 26.01M | 11.84M |
| Total Debt | 9.41M | 12.60M | 15.35M | 11.02M | 9.61M | 15.84M |
| Total Liabilities | 16.64M | 18.39M | 19.40M | 15.56M | 13.87M | 21.58M |
| Stockholders Equity | 30.35M | 32.76M | 30.85M | 41.98M | 47.00M | 20.30M |
Cash Flow | ||||||
| Free Cash Flow | -5.37M | -2.00M | -11.18M | -13.72M | -12.55M | -11.70M |
| Operating Cash Flow | -4.87M | -531.00K | -8.69M | -8.24M | -7.66M | -8.57M |
| Investing Cash Flow | -1.54M | -1.13M | -1.76M | -7.29M | -4.75M | -2.05M |
| Financing Cash Flow | -2.01M | 11.08M | 5.71M | 5.42M | 26.58M | 14.44M |
Fermentalg SA Technical Analysis
Positive
0.43
Price Trends
0.45
Positive
0.44
Positive
0.47
Positive
Market Momentum
0.02
Negative
55.11
Neutral
70.30
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For FR:ALGAE, the sentiment is Positive. The current price of 0.43 is below the 20-day moving average (MA) of 0.46, below the 50-day MA of 0.45, and below the 200-day MA of 0.47, indicating a bullish trend. The MACD of 0.02 indicates Negative momentum. The RSI at 55.11 is Neutral, neither overbought nor oversold. The STOCH value of 70.30 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for FR:ALGAE.
Fermentalg SA Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
60 Neutral | €8.91M | -15.91 | ― | ― | ― | ― | |
52 Neutral | €45.24M | -3.30 | -33.26% | ― | 59.05% | 56.18% | |
52 Neutral | €127.52M | -24.25 | -85.59% | ― | -10.91% | -25.57% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
48 Neutral | €24.11M | -1.75 | ― | ― | ― | ― |
* Healthcare Sector Average
FR:ALGAE
Fermentalg SA
0.51
0.21
68.33%
FR:ALCOX
Nicox SA
0.43
0.21
91.52%
FR:ABNX
ABIONYX Pharma SA
3.62
2.47
215.33%
FR:ALVAL
Valbiotis SA
1.02
0.03
2.52%
FR:ALNFL
NFL Biosciences SA
1.08
-0.28
-20.53%
FR:ALPAT
Plant Advanced Technologies SA
7.90
-2.45
-23.67%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.